samedan logo
 
 
 
spacer
home > ebr > spring 2003 > fast track project implementation: risk or reward?
PUBLICATIONS
European Biopharmaceutical Review

Fast Track Project Implementation: Risk or Reward?

New technology products, particularly those with a long regulatory approval time, often come under extreme pressure in the industrialisation stage - taking the product from bench or small scale up to full manufacturing scale. Key to success are project definition, risk management, effective teamwork and supply chains, and controlled handover and validation.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Gareth Davies, Operations Director at CEL International

Gareth Davies is Operations Director with CEL International in Coventry. A Chemist by training, Gareth has a process operational background and over 15 years' experience in projects ranging from 1/2 million to 140 million and in diverse applications from biotechnology through pharmaceuticals and food production to man-made fibres and chemicals. A core member of the recent task group sponsored by the Department of Trade and Industry to define best practice for fast track projects, Gareth led CEL's teams on the 2001 and 2002 ACTIVE 'Project of the Year' projects, the latter having been won against pan-European competition.

spacer
Gareth Davies
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Discussing developments on Highly Potent APIs with industry expert, Richard Arnett for the HPAPI USA conference 2019

Ahead of the 2019 HPAPI USA Conference taking place in Boston on 21st 22nd October, SMi caught up with Richard Arnett, Manager, Industrial Hygiene, Pharmascience who is speaking on Day Two of the agenda. Richard shared his thoughts on how the industry has developed and briefly touched on what he will be discussing in October.
More info >>

White Papers

Autoinjector testing made safe efficient and flexible

ZwickRoell

The autoinjector market is one of the fastest growing markets across almost all pharmaceutical applications. Studies expect a global market volume of approximately USD 2.5 billion by 2020, with pre-filled autoinjectors representing the largest market segment. There are a variety of tests that can be performed on autoinjectors, and these are well-demonstrated by the Zwick product portfolio. The Ulm-based company and specialist in testing systems offers a variety of testing systems that are already being successfully used by multiple pharmaceutical companies.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement